Trials / Unknown
UnknownNCT03305705
Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue
Double-Blind, Single-Center Interventional Trial To Evaluate The Effect Of Intravenous Iron Versus Placebo On Cerebral Dopamine Receptor Density In Non Anaemic Premenopausal Women With Low Ferritin Levels And Fatigue
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Albina Nowak, MD · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the effect of intravenous iron substitution in non-anaemic premenopausal women with iron deficiency on: * Changes in the cerebral Dopamine (DA) receptor density after iron substitution, shown by brain PET * Reduction of fatigue and other neuropsychological symptoms after iron supplementation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iron Carboxymaltose | Single intravenous infusion within 20 min |
| DRUG | Sodium chloride 0.9% | Single intravenous infusion of 250 ml within 20 min |
Timeline
- Start date
- 2017-10-23
- Primary completion
- 2019-08-31
- Completion
- 2019-08-31
- First posted
- 2017-10-10
- Last updated
- 2017-10-13
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03305705. Inclusion in this directory is not an endorsement.